VTv's HPPD Receives FDA Orphan Drug Status For Sickle Cell Disease

The U.S. FDA granted Orphan Drug Status to vTv Therapeutics’ HPPD (HPP8668) for the treatment of sickle cell disease. The designation is a positive regulatory development; the article provides no development timeline, financial details, or market reaction.